Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
MDC
|
David E Blackford
Director |
SELL
Open market or private sale
|
Direct | 16,250 Reduced 54.85% |
$479,212
$29.49 p/Share
|
Feb 24
2017 |
CSCO
|
Chris Dedicoat
EVP, Worldwide Sales & Fld Ops |
SELL
Open market or private sale
|
Direct | 34,597 Reduced 13.11% |
$1,180,450
$34.12 p/Share
|
Feb 24
2017 |
ARE
|
Thomas J Andrews
Co-President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.88% |
$598,400
$119.68 p/Share
|
Feb 24
2017 |
DHR
|
Robert S Lutz
SVP-Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 37,870 Reduced 59.1% |
$3,241,672
$85.6 p/Share
|
Feb 24
2017 |
INTC
|
Diane M Bryant
EVP and Group President |
SELL
Open market or private sale
|
Direct | 55,821 Reduced 34.22% |
$2,028,535
$36.34 p/Share
|
Feb 24
2017 |
UPS
|
Teri P Mc Clure
CHRO & SVP, Labor Relations |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 100.0% |
$471,825
$104.85 p/Share
|
Feb 24
2017 |
NEM
|
William N Mac Gowan
EVP, Human Resources |
SELL
Open market or private sale
|
Direct | 2,006 Reduced 2.26% |
$72,838
$36.31 p/Share
|
Feb 24
2017 |
TSLA
|
Antonio J. Gracias
Director |
SELL
Open market or private sale
|
Direct | 5,466 Reduced 100.0% |
$1,392,245
$254.71 p/Share
|
Feb 24
2017 |
RTX
|
Robert J. Bailey
Corporate VP, Controller |
SELL
Open market or private sale
|
Direct | 1,022 Reduced 100.0% |
$114,730
$112.26 p/Share
|
Feb 24
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,398 Reduced 0.21% |
$112,980
$20.93 p/Share
|
Feb 24
2017 |
MDC
|
David E Blackford
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 27.21% |
$147,000
$29.4 p/Share
|
Feb 23
2017 |
MDC
|
David E Blackford
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 27.21% |
$145,900
$29.18 p/Share
|
Feb 23
2017 |
MAS
|
Lisa A Payne
Director |
SELL
Open market or private sale
|
Direct | 1,949 Reduced 3.18% |
$66,052
$33.89 p/Share
|
Feb 23
2017 |
SNPS
|
Steven Walske
Director |
SELL
Open market or private sale
|
Direct | 9,074 Reduced 34.69% |
$644,435
$71.02 p/Share
|
Feb 23
2017 |
NEM
|
E Randall Engel
EVP, Strategic Development |
SELL
Open market or private sale
|
Direct | 675 Reduced 0.31% |
$24,665
$36.54 p/Share
|
Feb 23
2017 |
FSLR
|
Paul J Kaleta
EVP, Genl Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 8,492 Reduced 26.38% |
$286,095
$33.69 p/Share
|
Feb 23
2017 |
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 100.0% |
$421,800
$21.09 p/Share
|
Feb 23
2017 |
ABT
|
Funck, Jr. Robert E.
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 25,500 Reduced 21.69% |
$1,160,250
$45.5 p/Share
|
Feb 23
2017 |
CSCO
|
Arun Sarin
Director |
SELL
Open market or private sale
|
Indirect | 13,869 Reduced 49.43% |
$472,378
$34.06 p/Share
|
Feb 23
2017 |
CSCO
|
Roderick C Mcgeary
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 7.53% |
$340,700
$34.07 p/Share
|
Feb 23
2017 |
CSCO
|
John T Chambers
Executive Chairman |
SELL
Open market or private sale
|
Direct | 250,000 Reduced 17.0% |
$8,515,000
$34.06 p/Share
|
Feb 23
2017 |
CSCO
|
John T Chambers
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 45,538 Reduced 50.0% |
$1,550,569
$34.05 p/Share
|
Feb 23
2017 |
ARE
|
Thomas J Andrews
Co-President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.73% |
$594,200
$118.84 p/Share
|
Feb 23
2017 |
SQ
|
Francoise Brougher
Business Lead |
SELL
Open market or private sale
|
Direct | 115,385 Reduced 55.38% |
$1,951,160
$16.91 p/Share
|
Feb 23
2017 |
TSLA
|
John Douglas Field
Senior VP, Engineering |
SELL
Open market or private sale
|
Direct | 500 Reduced 3.3% |
$128,770
$257.54 p/Share
|
Feb 23
2017 |
HD
|
Carol B Tome
CFO & EVP - Corp. Services |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 15.38% |
$14,525,000
$145.25 p/Share
|
Feb 23
2017 |
HD
|
Timothy M Crow
EVP - Human Resources |
SELL
Open market or private sale
|
Direct | 88,253 Reduced 30.16% |
$12,846,990
$145.57 p/Share
|
Feb 23
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,999 Reduced 0.2% |
$105,179
$21.04 p/Share
|
Feb 23
2017 |
AAPL
|
Johny Srouji
Senior Vice President |
SELL
Open market or private sale
|
Direct | 6,207 Reduced 6.53% |
$850,359
$137.0 p/Share
|
Feb 22
2017 |
ABT
|
Roger Bird
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 12,903 Reduced 17.03% |
$581,022
$45.03 p/Share
|
Feb 22
2017 |
TRU
|
Samuel A Hamood |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 60.1% |
$2,194,200
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
James M Peck
Director |
SELL
Open market or private sale
|
Indirect | 65,000 Reduced 12.15% |
$2,377,050
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Gerald M Mc Carthy Jr
EVP - Healthcare |
SELL
Open market or private sale
|
Direct | 11,000 Reduced 27.46% |
$402,270
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
John T Danaher
President, Consumer Inter |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 21.16% |
$365,700
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Siddharth N Mehta
Director |
SELL
Open market or private sale
|
Direct | 150,000 Reduced 37.3% |
$5,485,500
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
George M Awad
Director |
SELL
Open market or private sale
|
Direct | 28,000 Reduced 58.16% |
$1,023,960
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Advent International Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,730,500 Reduced 25.98% |
$355,844,382
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Advent International Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,730,500 Reduced 25.98% |
$355,844,382
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Steven M Tadler
Director |
SELL
Open market or private sale
|
Indirect | 157,634 Reduced 25.98% |
$5,764,675
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Christopher Egan
Director |
SELL
Open market or private sale
|
Indirect | 163,472 Reduced 25.98% |
$5,978,171
$36.57 p/Share
|
Feb 22
2017 |
AMP
|
Karen Wilson Thissen
Executive VP and GC |
SELL
Open market or private sale
|
Direct | 535 Reduced 9.13% |
$70,176
$131.17 p/Share
|
Feb 22
2017 |
NBHC
|
Maria F Spring |
SELL
Open market or private sale
|
Direct | 3,208 Reduced 10.78% |
$106,089
$33.07 p/Share
|
Feb 22
2017 |
SNPS
|
Trac Pham
CFO |
SELL
Open market or private sale
|
Direct | 39,899 Reduced 76.64% |
$2,842,405
$71.24 p/Share
|
Feb 22
2017 |
TRU
|
David M Neenan
President, International |
SELL
Open market or private sale
|
Indirect | 90,000 Reduced 17.37% |
$3,310,200
$36.78 p/Share
|
Feb 22
2017 |
TRU
|
Gscp Vi Advisors, L.L.C. |
SELL
Open market or private sale
|
Indirect | 9,730,500 Reduced 17.53% |
$355,844,382
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Goldman Sachs Group Inc |
SELL
Open market or private sale
|
Indirect | 9,730,500 Reduced 17.53% |
$355,844,382
$36.57 p/Share
|
Feb 22
2017 |
TRU
|
Sumit Rajpal |
SELL
Open market or private sale
|
Indirect | 9,730,500 Reduced 17.53% |
$355,844,382
$36.57 p/Share
|
Feb 22
2017 |
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 100.0% |
$428,000
$21.4 p/Share
|
Feb 22
2017 |
EVR
|
Adam B Frankel
General Counsel |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 1.86% |
$96,900
$80.75 p/Share
|
Feb 22
2017 |
AAPL
|
Albert Gore Jr
Director |
SELL
Open market or private sale
|
Direct | 215,437 Reduced 48.35% |
$29,454,547
$136.72 p/Share
|
Feb 22
2017 |